The four conference tracks at this event include; Advances in qPCR, which will showcase new developments in qPCR technology and its wide range of applications. Sessions will focus on improvements to qPCR design, the acquisition of accurate data, and efficient data analysis. There will also be presentations demonstrating the role of qPCR in molecular diagnostics and the detection of tumour cells. RNAi & miRNA track will detail the cutting edge research taking place in the two fields with a particular emphasis on the complex roles microRNA play in cancer and their regulation. The latest developments in both therapeutics and delivery…

The four conference tracks at this event include Biotherapeutics, Single Use Technologies, Stem Cells and Cell Culture. Registered delegates will have access to all four meetings ensuring a very cost-effective trip. For more information on each track visit our website.

Welcome to our European Lab Automation congress and exhibition, Europe's largest event dedicated to automation within life science. Offering over 150 scientific presentations across 8 different conference streams linked with an exhibition containing more than 150 equipment vendors, ELA aims to highlight and showcase the latest in automated instruments and workflows. Life science researchers and professionals are presented with an unparalleled opportunity to foster technological discussions and scientific collaboration. Registration for ELA 2012 is now open, with all conference delegates having the opportunity to attend all 8 conference streams.

Welcome to the Flow Chemistry Congress and exhibition. The primary focus of this 2nd meeting will be on the use of enabling technologies in synthetic chemistry and continuous flow chemistry. Under the auspices of the Flow Chemistry Society a line-up of experts from academia and industry, supported by invited lecturers, will address the latest advances in the field. Delegates will also have the chance to share their research in planned poster sessions as well as having access to an extensive exhibition of world leading equipment vendors.

Genomics Research 2012 aims to provide a technical programme that encompasses all of the cutting edge topics within Genomics Research, with a particular focus on its application in the development of therapeutics and diagnostics. Network with over 400 of your peers and 50 exhibiting companies to create partnerships and collaborations to advance your research. It will encompass our successful RNAi & miRNA, Advances in qPCR, Epigenetics, Next Gen Sequencing conference streams as well as and Genomic Biomarkers. This year's event will be held in Boston. Registered delegates will have access to all five meetings ensuring a very cost-effective trip. Click…

Welcome to the Lab-on-a-Chip conference and exhibition. This year's event will be held in the historic city of Edinburgh. The Lab-on-a-Chip European Congress will bring together leaders from both academia and industry to discuss innovative developments in this exciting field, with presentations exploring the latest advances in microfluidics and microfabrication. Attention will also be given to some of the many applications of Labs-on-Chips, from the enhancement of life science research, to taking diagnostics to the point of need. Unrestricted access between the Lab-on-a-Chip European congress and the co-located Single Cell Analysis Europe, Advances in Biodetection & Biosensors, and Advances in…

Overview: Attend this webinar to understand the differences and benefits of verification and validation. Learn about the risks and complications involved with the application of sound verification and validation principles. Why Should You Attend: The meanings and regulatory requirements of the terms "verification" and "validation" are often confusing to engineers and even some regulatory professionals. FDA regulations as well as European standards such as ISO 13485:2003 require both verification & validation documentation throughout these regulations and standards.The terms apply to design control, process control and others. Verification and validation also appear in the "essential requirements" in MDD 93/42/EEC needed for…

Overview: This webinar will give a good understanding of FDA and international expectations for auditing computer systems and provide steps for cost-effective implementation. Auditing of computer systems is important to verify compliance of the systems with regulations and internal standards. When done right, audits can help to improve quality of computer system operation and uptime. In addition audits are also an excellent tool to prepare your organization and staff for external audits, e.g., FDA inspection. However, without a clear strategy audits can become quite complex and ineffective. Reference material for easy implementation: SOPs: Validation of Commercial Off-the-Shelf Computer Systems Checklist:…

Overview: This webinar details both regulations and provides details for implementing computerized systems. Learn exactly what is needed to be compliant for all three primary compliance areas: SOPs for the IT infrastructure, industry standards for software product features, and the 10-step risk-based validation approach. This webinar demystifies Part 11 and the new European equivalent Annex 11. It gets you on the right track for using electronic records and signatures to greatly increase productivity. Areas Covered in the Session: Which data and systems are subject to the regulations? What the regulations mean, not just what they say. Avoid 483 and Warning…

Overview: This interactive webinar provides explicit details and live demonstration followed by a collaborative workshop that explains how to configure and validate a GxP compliant spreadsheet application. What makes this session unique is the combination of step-by-step instructions and the hands on workings of each participant. Bring your laptop and use Excel for your own needs. This session will make you a better Excel user, saving you time and costs. Areas Covered in the Session: Develop spreadsheet applications that are GxP compliant. Avoid 483s and warning letters. What does and does not need to be validated. Learn how to use…

Overview: FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies. One major failing is lack of sufficient or targeted risk-based company-wide V&V planning. Starting with a Master Validation Plan, evaluating its elements against ISO 14971 hazard analysis / risk management, allows development of meaningful product validations. The roles of different V&V protocols. How to employ equipment / process DQs, IQs, OQs, and PQs, or their equivalents per ASTM E2500, against a background of limited company resources (personnel, budget, time). A matrix simplifies "as-product", "in-product", process, and equipment, et al, software V&VT, assuring key FDA requirements…

Overview: This webinar will examine the existing and proposed requirements for the FDA's DHF -- including its derivative documents, the DMR and DHR. It will consider the MDD's TF/DD requirements, and evaluate the documents' differing purposes / goals. Required and desirable contents will be discussed. Also considered: Areas requiring frequent re-evaluation / update; Similarities and differences; Future trends; Typical DHF Table of Contents; Technical File or Design Dossier Table of Contents; The importance and usefulness of the "Essential Requirements"; Structure of the "Declaration of Conformity"; self-declaring or N-B reviewed; Parallel approaches to development. Finally, the differing approaches to file audits…

Overview: This webinar is focused on understanding the requirements of the Medical Device Directives, their linkage to the EU Clinical Trial Directive and the requirements of CE Marking and ISO Certification on commercializing products. This Medical Device Directive training will be discussing the recently implemented and currently planned changes to the Medical Device Directives across the EU. It includes specific insight from direct involvement and work within the EU and the Commission's major improvement objectives to their system today. Specific targeted areas for change is discussed as well as the likely implementation timetable. Key Topics to be Discussed: The current…

Advances in Biodetection and Biosensors is now in its 5th year and is going from strength to strength. This year, we are expanding the meeting to incorporate more focus on Biosensors. Biosensors are small analytical devices that can convert a biological stimulus into an electrical signal. These can be for things such as measuring concentrations of substances within the body and are extremely valuable in rapidly detecting when these levels change. For example, biosensors could be extremely valuable to diabetics in rapidly informing the individual when blood glucose levels fluctuate out of normal parameters. The conference will also cover other…

Select Biosciences 3rd Single Cell Analysis conference for 2012 will build on the successes of the previous events, by continuing to deliver relevant presentations on the latest developments in the field from a expert line up of speakers. Single Cell Analysis is a rapidly expanding discipline which focuses on detecting minute differences in individual cells, which could provide game changing advances in medical testing and treatment. Dr Marcus Textor of ETH Zurich will be giving his Keynote Presentation on Cell Culture in 2D and 3D Based on Microfabricated Culture Substrates, which promises to be an exciting and interesting talk to…

This conference will discuss the wide range of cutting edge research being conducted using Microarray technologies in various scientific fields. Focusing on areas such as DNA/Protein expression profiling and genotyping, tissue arrays for histological analysis and biomarker discovery, an overview of the diverse work being carried out in this important field will be given. Across both the conference and exhibition we also aim to keep researchers in the field up to date with the latest microarray tools and analytical techniques available.

Our 2012 ADME & Predictive Toxicology Congress conference will to report on the vital role ADME and Predictive Toxicology play in aiding successful drug candidate identification and design. Ensuring drugs make it to the market quicker with higher hit rates and earlier indications of human toxicity issues is of the utmost importance and will be discussed at length here. Our array of Keynote Speakers will give presentations on all areas of ADME/Tox backed up by a panel of expert speakers speaking on highly relevant and “hot” topics such as Pharmacogenomics and Drug Safety, Genotoxicity and Toxicokinetic Modeling and ADME Optimisation…

The 2nd International Conference of the Flow Chemistry Society aims to unite and represent those who are actively working on this rapidly developing field. As the societies main European meeting, it is dedicated to the integration of flow chemistry into everyday practice throughout the world by delivering the latest knowledge and making it available for the entire chemistry community. Keynote Speaker Dr Oliver Kappe will be presenting his fascinating work on the translation of flash vacuum pyrolysis protocols to solution-phase high-temperature/pressure flow reaction conditions, whilst Dr Neal Sach will be sharing his experiences on the applications of flow technology in…

This year’s Discovery Chemistry Congress will focus on four of the most important aspects of effective drug design and development: Fragment Based Lead Discovery, Structural and Computational Chemistry, Formulation and Solubility and Chemistry Outsourcing, ensuring attendees receive an excellent overview of the latest developments in the field. For more information on each of these tracks visit our website.

Avoidable readmissions cost Medicare, the federal health plan for the elderly and disabled, an estimated $17 billion per year. One of the largest areas against which hospitals are being measured is preventing avoidable readmissions. Hear how Lean, Six Sigma and other process improvement technologies can be deployed to prevent avoidable readmissions.